MedPath

Comparison of Ketamin/Propofol (Ketofol) and Etomidate /Fentanyl (Etofen) in reduction of shoulder dislocatio

Phase 2
Recruiting
Conditions
Anterior Shoulder Dislocation.
Subluxation and dislocation of shoulder joint
S43.0
Registration Number
IRCT20220824055790N1
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
46
Inclusion Criteria

Adults between 18 and 50 years old
Anterior shoulder dislocation

Exclusion Criteria

History of allergy to any of the drugs (ketamine, propofol, etomidate, fentanyl)
underlying cardiovascular disease
lung diseases
nervous system diseases (central or peripheral)
history of current drug or stimulant abuse now or in the last month
associated fracture
neurovascular symptoms
patient dissatisfaction
associated diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain score: using numerical rating scale. Timepoint: During Reduction. Method of measurement: Ask the patient: Score from 1 to 10.;Number of reduction attempts until reduction succeeds. Timepoint: During study until reduction succeeds. Method of measurement: -.;Length of stay in the emergency room: the time between the patient's admission to the emergency room and discharge. Timepoint: After discharge. Method of measurement: View the patient file.;Drug side effects: bradycardia, respiratory depression, hypotension. Timepoint: During Study. Method of measurement: Based on the form of drug side effects.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath